Best blood thinner plan for atrial fibrillation after stent
Part of Brain & nervous system, Heart & circulation clinical trials.
This study compares different blood-thinner (“antithrombotic”) strategies in people with atrial fibrillation or flutter who recently had a stent placed (PCI). It aims to find a plan that lowers clot risk while keeping bleeding risk as low as possible.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are age 18 or older
- You recently had a stent procedure (PCI), either urgent or planned
- You have atrial fibrillation/flutter that is either known already or started within 72 hours after the heart event
- You have a long-term reason to take oral anticoagulation (a long-term blood thinner) for at least 1 year
- You do not have conditions that make blood thinners (edoxaban, aspirin, or P2Y12 medicines) unsafe
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares two ways to manage blood-thinning medications after a successful atrial fibrillation ablation, specifically for people who also have a heart stent. It aims to find the safest and most effective strategy to prevent strokes and bleeding.
This study tests whether taking dabigatran (a blood thinner) combined with ticagrelor (a blood clot preventer) is safe and effective for patients with irregular heart rhythm (atrial fibrillation) who recently had a heart attack and received a stent. The goal is to prevent future blood clots while minimizing bleeding risks.
This trial tests whether using a blood thinner in people with new, temporary atrial fibrillation after CABG (heart bypass surgery) can reduce harmful outcomes compared with standard treatment. It may help prevent stroke or other complications if your rhythm problem fits the trial’s timing and risk profile.
This study tests whether taking a single blood-thinning medication (instead of two) after heart stent placement is safe and effective over the long term. If you've recovered well from a stent procedure, this trial may help determine the safest way to prevent future heart problems.
This trial tests whether starting blood thinners soon after a procedure to remove a blood clot from the brain can safely prevent another stroke in people who have atrial fibrillation. Participation is for those who had a severe stroke, received the clot-removal procedure, and are medically stable afterward.
This study compares two blood-thinning medicines to see which works better for people who have both atrial fibrillation (irregular heartbeat) and heart disease. It aims to reduce the risk of heart attack or stroke while avoiding bleeding problems.
Hear when a new Acute Coronary Syndrome trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.